Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -2.13% 115.00 113.00 117.00 117.50 115.00 117.50 70,852 16:18:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 6.1 -13.9 -35.9 - 65

Reneuron Share Discussion Threads

Showing 7851 to 7872 of 8350 messages
Chat Pages: Latest  322  321  320  319  318  317  316  315  314  313  312  311  Older
DateSubjectAuthorDiscuss
05/3/2020
17:26
Covid 19 cure is what mkt is looking for.... Anything else gets sold off atm.
napoleon 14th
05/3/2020
16:13
Up isn't a word than can be used on this site. Reneuron doesn't have a friend. So soon after good RP trial results the performance of the shares is shocking.
dickbush
05/3/2020
15:18
Only 60,000 shares traded but we are down another 10%. You couldn't make it up.
investordave
05/3/2020
14:43
Manc I’ve been taking Puritan Pride Red yeast for approximately 3 months now for two main reasons 1) To reduce my High Cholesterol level 2) Suffered severe side effects (Muscle ache) from statins and needed an alternative.I have also tried plant sterols and suffered similar side effects too. I'm not sure if they contain any monacolin and haven’t had a blood test yet to see if they actually work in reducing my Cholesterol, but I can tolerate them without any side effects. I'm due a 6 month checkup soon and will find out if Cholesterol has reduced. According to the label - anyone thinking of taking Red yeast should take COQ10 with it for best results.
cashflow66
28/2/2020
09:12
Nobody is at all interested in what you have to say Kenny boy. So be off with you and leave us to wallow in peace.
investordave
25/2/2020
22:21
Just dreaming..zzzz....Wonder if after 12 months improvement, a patient might be offered a second dose to see if further improvement is possible, then another, and another....
alimo
25/2/2020
15:12
Had a look at the interview. Mentioned 10 patients treated. Does that mean 2 more have been treated in the last month? No mention in either RNS or interview about surgical issues arising. That's encouraging. Next study, placebo controlled arm. I wonder if this includes sham surgery. Seems harsh, if true, given the surgical risks are not zero. Out of interest, are the individual letters moved around on the eye charts to limit bias induced by memorising?
hashertu
25/2/2020
12:48
And a new video on the Proactive website discussing the latest news. At work at the moment so cannot watch it :(
pdt
25/2/2020
11:57
Good to see yesterday's positive news. The FDA have approved eye products with as little as a 5 letter improvement. I would hope that when all 8 patients reach the 12 month stage the average will be greater than 5. The numbers at this stage suggest they will be. And with RP the alternative is to do nothing and eventually lose all sight. Even with the surgery risk it is a risk worth taking. Eylea for example I understand improves vision in the 8 to 11 letter range. A treatment for AMD with annual sales over $4 billion. And it is interesting that they are doubling the dose to 2 million cells. If they could sustain a 20 plus letter gain then they really would have an amazing product. I guess cash will become a worry at some stage but these better results may encourage a partner before that stage is reached.
pdt
24/2/2020
19:29
Better to pop down to Kwik Fit and swap out the whole thing for the new improved model :) The horror! The horror!
supernumerary
24/2/2020
17:48
Yes, brain implants needed for presbyopia. One day.
small crow
24/2/2020
16:23
personally think these results are excellent, all things considered
martinfrench
24/2/2020
15:06
That's clever! Unfortunately none of these solutions really address the problem of presbyopia - what's needed is a way of making the lens more flexible, not just more or less powerful. I imagine it will come (or perhaps it's here and I haven't heard of it yet?).
supernumerary
24/2/2020
14:56
Also consider "Light Adjustable Lenses" SC as they can be put into the eye and altered/adjusted when actually inside the eye by shining various frequency light at them and then locking them into shape when the optimum configuration is achieved.
algernon2
24/2/2020
14:29
PS Yes, that's one reason I've always avoided laser .... eyes do change and you cannot undue. Better option, which I might consider for one of my eyes (the more astigmatic) is an intraocular lens. You can always take it out and stuff in another.... for a price.
small crow
24/2/2020
14:27
Agreed. I think the only "downside" is that things may be as good as they get after 12 months, rather than continuing to improve. However, if your sight is going to probably don't want to wait 3 years for improvement and, also positive, this is just the first draft of a therapeutic. Things can only get better, as Mr Blair used to say.
small crow
24/2/2020
12:32
sc - I've had the same transition - started short-sighted (very!), had it fixed by laser (giving excellent all-round vision), and now long-sighted and forever fiddling with pairs of reading glasses - infuriating! I also think the news is reassuring. The first requirement is always that things shouldn't get worse, and I think we can now safely abandon that possibility. So we're only looking at degrees of success, which is a nice position to be in. I'm also pleased they're now showing improvement of treated eye over untreated, rather than just improvement over baseline, as that eliminates some of the baseline movement which might occur with age-related changes, or variations in general health.
supernumerary
24/2/2020
11:06
Yes, thanks super, I still think that's what might be happening. The most common cause of people wearing glasses for years and then not needing them is that most of us tend to become more 'long-sighted' as we age, so all of those who needed correction for short-sight (ie loads of us) tend to need them less as we get older. I'm typical - my eyes have shifted about +2 diopter units over the last 40 years - I used to need specs for driving but not now. Anyway, The data looks a bit better with increasing samples but I would guess the market is still worried about a potential decline in acuity after 9 months and will want to see a longer time series. FWIW, my opinion is that the better measurement to use, as a real indicator of the improvement as perceived by the patient, is the sum of the improvement in both eyes. On that measure the improvement in what they see (ie with both) begins at around 12 units, increases to 24 units at 9 months, and declines far less between 9 and 12 months. Either way, I suspect the market is reassured (ie no catastrophe) but will need to see more before hands go in pockets.
small crow
24/2/2020
10:17
cotton - I think this is a more likely explanation: small crow26 Oct '19 - 10:32 - 7427 of 7560 0 1 1 Nobby, thanks for that. I'm not that surprised that the untreated eye seems to improve as you have to factor in the computational stuff between the retina and the "perception" to get the final result. It could be the case that better input to the visual centres/optic tectum is causing changes that benefit the signal processing in both eyes. It's like a mild case of the groundbreaking Colin Blakemore experiment where he demonstrated that, if you raise animals from birth in an environment where they never see a horizontal line, then transfer them to a regular environment, they can't perceive horizontal lines. In this case the signal processing is not used to processing a "sharp" image but, once presented with one, gets better at doing it. It's an idea and, more importantly, good news for both eyes.
supernumerary
24/2/2020
09:43
It is a really, really bad day for the market. Not declining with it is a major achievement.
dickbush
24/2/2020
08:52
ID, Rene is fickle, news comes out and sometimes it takes it time to react. Rather have positive news than the other but just wish we could get that good one in order to get things moving. Zoo
zooman
24/2/2020
08:19
Oh well. Looks like the market doesn't think much of that update either.
investordave
Chat Pages: Latest  322  321  320  319  318  317  316  315  314  313  312  311  Older
ADVFN Advertorial
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210624 04:08:30